Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA LBW242 CCLE pan-cancer AAC 0.056 0.2
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.042 0.2
mRNA AZD6244 CCLE pan-cancer AAC -0.051 0.2
mRNA thalidomide CTRPv2 pan-cancer AAC -0.065 0.2
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA HBX-41108 CTRPv2 pan-cancer AAC -0.05 0.2
mRNA NPC-26 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC -0.067 0.2
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.045 0.2
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.045 0.2
Download CSV